A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of Secondary Infections in Febrile, Neutropenic Patients with Cancer-Reference-Cited by-同舟云学术

A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of Secondary Infections in Febrile, Neutropenic Patients with Cancer

Published:2005-01-15 Issue:2 Volume:40 Page:239-245
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:Clinical Infectious Diseases

Author:

Akova M.,Paesmans M.,Calandra T.,Viscoli C.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/40/2/239/1021369/40-2-239.pdf

Reference16 articles.

1. Treatment of febrile neutropenia: what is new?

2. Epidemiology and Risk Factors for Gram‐Positive Coccal Infections in Neutropenia: Toward a More Targeted Antibiotic Strategy

3. Serum antibodies against common antigens of bacterial lipopolysaccharides in healthy adults and in patients with multiple myeloma

4. Risk Factors and Attributable Mortality Associated with Superinfections in Neutropenic Patients with Cancer

5. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-Risk Neutropenic Fever and Invasive Fungal Diseases in Patients with Hematological Malignancies;Microorganisms;2024-01-06

2. Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients;The Lancet Infectious Diseases;2024-01

3. Neutropenia febbrile in Pronto Soccorso;EMC - Urgenze;2023-06

4. New approaches to management of fever and neutropenia in high-risk patients;Current Opinion in Infectious Diseases;2022-08-10

5. [18F]FDG-PET-CT compared with CT for persistent or recurrent neutropenic fever in high-risk patients (PIPPIN): a multicentre, open-label, phase 3, randomised, controlled trial;The Lancet Haematology;2022-08